Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -2.37%-9.55M | ---- | -279.03%-9.32M | ---- | -48.62%5.21M | ---- | 124.29%10.14M | ---- | -214.62%-41.73M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 32.68%-1.79M | ---- | -52.99%-2.66M | ---- | -1,571.15%-1.74M | ---- | 85.85%-104K | ---- | 57.88%-735K |
| Impairment and provisions: | ---- | -1,104.71%-854K | ---- | 110.25%85K | ---- | -217.59%-829K | ---- | -87.58%705K | ---- | --5.68M |
| -Other impairments and provisions | ---- | -1,104.71%-854K | ---- | 110.25%85K | ---- | -217.59%-829K | ---- | -87.58%705K | ---- | --5.68M |
| Asset sale loss (gain): | ---- | -470.27%-137K | ---- | 192.50%37K | ---- | -600.00%-40K | ---- | 101.79%8K | ---- | -114.42%-446K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -470.27%-137K | ---- | 192.50%37K | ---- | -600.00%-40K | ---- | 101.79%8K | ---- | -114.42%-446K |
| Depreciation and amortization: | ---- | -7.70%647K | ---- | -10.24%701K | ---- | -4.17%781K | ---- | -81.18%815K | ---- | -7.97%4.33M |
| Financial expense | ---- | -70.00%3K | ---- | --10K | ---- | ---- | ---- | ---- | ---- | 33.33%4K |
| Operating profit before the change of operating capital | ---- | -4.72%-11.68M | ---- | -429.69%-11.15M | ---- | -70.74%3.38M | ---- | 135.14%11.56M | ---- | -184.01%-32.9M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 618.95%21.44M | ---- | -459.30%-4.13M | ---- | 107.11%1.15M | ---- | -227.22%-16.17M | ---- | 48.79%12.71M |
| Accounts payable increase (decrease) | ---- | -2,400.52%-29.06M | ---- | -113.03%-1.16M | ---- | 271.01%8.92M | ---- | 43.66%-5.21M | ---- | -134.24%-9.25M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | 66.84%24.68M | ---- | -60.62%14.79M | ---- | 178.47%37.57M |
| Cash from business operations | 47.78%-6.11M | -17.30%-19.29M | 54.15%-11.69M | -143.13%-16.44M | -216.57%-25.5M | 666.43%38.13M | 267.51%21.88M | -38.77%4.98M | -133.34%-13.06M | -69.73%8.13M |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 262.25%2.67M | ---- | 81.20%-1.65M |
| Special items of business | ---- | 232.73%15.09M | ---- | ---11.37M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 47.78%-6.11M | 84.92%-4.2M | 54.15%-11.69M | -172.95%-27.82M | -216.57%-25.5M | 398.82%38.13M | 267.51%21.88M | 17.96%7.64M | -133.34%-13.06M | -64.19%6.48M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 5.44%620K | -32.68%1.79M | -58.36%588K | 52.99%2.66M | 659.14%1.41M | 1,571.15%1.74M | 148.00%186K | -84.71%104K | -86.06%75K | -57.39%680K |
| Decrease in deposits (increase) | 84.29%-10.17M | -24.91%14.78M | -650.11%-64.71M | 192.67%19.69M | 28,790.24%11.76M | 15.47%-21.24M | 99.79%-41K | -248.15%-25.13M | ---19.36M | 200.53%16.96M |
| Sale of fixed assets | ---- | 6,566.67%400K | --280K | -85.00%6K | ---- | 3,900.00%40K | ---- | -99.99%1K | ---- | 4,402.88%9.37M |
| Purchase of fixed assets | ---- | 51.85%-195K | ---194K | 72.49%-405K | ---- | -303.29%-1.47M | ---307K | -479.37%-365K | ---- | 99.59%-63K |
| Purchase of intangible assets | ---- | ---6.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---13M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 85.09%-9.55M | 14.89%10.28M | -586.04%-64.04M | 142.72%8.95M | 8,232.72%13.18M | 17.54%-20.94M | 99.16%-162K | -194.23%-25.39M | -223.28%-19.28M | 271.51%26.95M |
| Net cash before financing | 79.33%-15.65M | 132.23%6.08M | -514.23%-75.73M | -209.76%-18.87M | -156.77%-12.33M | 196.88%17.19M | 167.14%21.72M | -153.09%-17.75M | -159.01%-32.35M | 1,302.69%33.43M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | ---- | ---- | ---- | ---- | ---6K | ---- | ---- | ---- | ---- | -33.33%-4K |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---39.99M | ---- | ---- |
| Other items of the financing business | ---- | 70.00%-3K | ---- | ---10K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 6.56%-57K | -0.80%-126K | -5.17%-61K | ---125K | ---58K | ---- | ---- | -70,057.89%-39.99M | ---- | -100.07%-57K |
| Net Cash | 79.27%-15.71M | 131.35%5.96M | -511.85%-75.79M | -210.49%-19M | -157.04%-12.39M | 129.78%17.19M | 167.14%21.72M | -273.03%-57.74M | -159.05%-32.35M | -62.51%33.37M |
| Begining period cash | 4.81%129.91M | -13.29%123.95M | -13.29%123.95M | 13.67%142.95M | 13.67%142.95M | -31.47%125.75M | -31.47%125.75M | 22.23%183.49M | 22.23%183.49M | 145.61%150.12M |
| Cash at the end | 137.12%114.2M | 4.81%129.91M | -63.11%48.16M | -13.29%123.95M | -11.47%130.56M | 13.67%142.95M | -2.43%147.47M | -31.47%125.75M | -26.23%151.14M | 22.23%183.49M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.